Similarities To Pradaxa Lawsuits Encourage Xarelto Lawsuit Plaintiffs As They Await Trial

February 22, 2016 – – BloodThinnerHelp.com reports on substantial commonalities contained in Xarelto and Pradaxa lawsuits, which now help to encourage the plaintiffs involved in current Xarelto lawsuits as they look ahead to trial. Xarelto lawsuits continue to grow in number today, both in Louisiana and in Pennsylvania. Those complaints which were filed federally have been consolidated by the United States Judicial Panel on Multidistrict Litigation to create MDL No. 2592. These cases now include more than 2,800 complaints. Involved plaintiffs have indicated that in the month of August 2015 alone, the MDL grew by 400 cases. It is anticipated that current numbers will continue to increase.

The MDL cases are being overseen by Judge Eldon Fallon in the Eastern District of Louisiana, but they are also joined by another group of more than 550 cases which were consolidated by the Court of Common Pleas to form a mass tort group in Philadelphia, Pennsylvania. All complaints name defendants Janssen Pharmaceuticals, (a division of Johnson & Johnson corporation), and Bayer AG.

The MDL cases are steadily progressing toward litigation at this time. Judge Fallon required that by January 11, 2016, 40 bellwether cases be selected to form a bellwether pool from which 4 final cases will be chosen to be prepared for bellwether trials in Spring of 2017. The plaintiffs involved in the Xarelto lawsuits all similarly claim that the blood thinner can cause sudden uncontrollable bleeding episodes among patients taking it.

Pradaxa shares similarities with Xarelto in that it is also a new-generation blood thinner. The drug was released by manufacturer Boehringer Ingelheim in 2010. As the public is seeing happen with Xarelto lawsuits today, shortly after Pradaxa’s market release, it was named in over 3,500 adverse event reports. Over 750 of these reports were fatalities, and therefore Pradaxa quickly became the topic of more than 4,000 lawsuits. One night before Pradaxa trials were scheduled to start, however, manufacturer Boehringer Ingelheim settled all lawsuits by paying $650 million to plaintiffs. Many Xarelto plaintiffs are also hoping for talks of settlement, and looking to this example as a possibility for them as well.

Attorney Joseph Osborne is attempting to help ensure that anyone who has been negatively affected by Xarelto will have the opportunity to investigate their legal rights. At this time, he is offering free consultations to qualified parties. It is believed that these patients may be entitled to substantial compensation.

To request further information, or ask questions regarding Xarelto lawsuits, please contact Attorney Joseph Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008265